029 Group SE

M&A Activity • Mar 17, 2005

News Details

Ad-hoc | 17 March 2005 08:36

Rhein Biotech N.V.:Rhein Biotech sells 100 % of Rhein Immuno BV shares

Ad hoc announcement §15 WpHG Rhein Immuno, take-over Rhein Biotech N.V.:Rhein Biotech sells 100 % of Rhein Immuno BV shares Ad hoc announcement transmitted by DGAP. The issuer is solely responsible for the content of this announcement. —————————————————————————— Rhein Biotech sells 100 % of Rhein Immuno BV shares to the company Mega Pharma S.A. The company Mega Pharma S.A., Uruguay, acquires from Rhein Biotech NV, 100% of the shares of Rhein Immuno BV, a daughter company of Rhein Biotech. The take- over includes the company PC-Gen S.A., a daughter company of Rhein Immuno BV. The transaction has been established on March 17, 2005 Rhein Biotech NV is a member of the Berna Biotech Group, a leading, innovative supplier of Vaccines. For more information Rhein Biotech N.V. Contact: Patrik Richard Corporate Secretary E: communications@bernabiotech.com Rhein Biotech N.V. Gaetano Martinolaan 95 6229 GS Maastricht Netherlands ISIN: NL0000230324 WKN: 919544 Listed: Geregelter Markt in Frankfurt (General Standard); Freiverkehr in Berlin-Bremen, Düsseldorf, Hamburg, Hannover, München und Stuttgart End of ad hoc announcement (c)DGAP 17.03.2005 170836 Mär 05